Former Chief Medical Officer · Korro Bio, Inc. (KRRO)

Kemi Olugemo

Kemi Olugemo, the former Chief Medical Officer at Korro Bio, Inc., received total compensation of $2341530 for fiscal year 2025. This amount included a base salary of $424667 and stock-based compensation of $1332108. No cash bonus or incentive was disclosed for this role.

A named executive officer of Korro Bio in every fiscal year CompBrief holds from FY2024 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$2,341,530

FY2024: $2,730,512

Compensation figures as of the proxy filed April 16, 2026 (DEF 14A).

Kemi Olugemo compensation by year

Korro Bio Summary Compensation Table · all 2 fiscal years held
In US dollars, as Korro Bio reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024FY2025
Salary$292,728$424,667
Bonus$0$0
Stock awards$0$0
Option awards$2,249,399$1,332,108
Non-equity incentive$180,320$0
Pension and deferred compensation$0$0
All other$8,065$584,755
Total$2,730,512$2,341,530

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Korro Bio, Inc. DEF 14A filed April 16, 2026, accession 0001193125-26-157895, and prior-year filings. Open the filing on EDGAR.

$2.7M
$2.3M
FY24
FY25
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
Option39,271—$50.48
Option33,250—$33.50

Per the Outstanding Equity Awards at Fiscal Year-End table in Korro Bio, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Korro Bio’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Ram AiyarChief Executive Officer, President and Interim Chief Financial Officer$3,119,591
Kemi Olugemo · this pageFormer Chief Medical Officer$2,341,530
Vineet AgarwalFormer Chief Financial Officer$1,719,273
Jeffrey CerioSenior Vice President, General Counsel and Corporate Secretary$1,578,451
Loïc VincentChief Scientific Officer$1,573,067

The full Korro Bio compensation record

free company brief

This page is one person within Korro Bio's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Korro Bio's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Korro Bio's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy